BCM
DMTK

Bayesian Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bayesian Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,200
Closed -$60K – 1084
2022
Q3 		$60K Buy
+15,200
New +$93.5K 0.01% 622

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bayesian Capital Management's DMTK Position: Q4 2022 in Review

Bayesian Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 15,200 shares — an estimated $60K sold.

Bayesian Capital Management first reported a position in DMTK in Q3 2022 and held it in 1 quarter. The position peaked at $60K in Q3 2022. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • Bayesian Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 15,200 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $60K.
  • Bayesian Capital Management first reported a position in DermTech, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Bayesian Capital Management's DermTech, Inc. Common Stock position peaked at $60K in Q3 2022.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.